Skip to main content
Zur Rose Group AG logo

Zur Rose Group AG — Investor Relations & Filings

Ticker · ROSE ISIN · CH0042615283 LEI · 50670038OH136R5Z4663 SW Wholesale and retail trade
Open in API
Filings indexed 477 across all filing types
Latest filing 2020-12-14 Legal Proceedings Report
Country CH Switzerland
Listing SW ROSE

About Zur Rose Group AG

https://www.zurrosegroup.com/websites/z…

DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.

Recent filings

Filing Released Lang Actions
Local Pharmacy Strengthening Act circumvents ECJ ruling
Legal Proceedings Report Classification · 99% confidence The document is a press release or news detail concerning a legal and regulatory dispute between DocMorris (an EU-based pharmacy) and German law regarding prescription drug bonuses. It discusses a new Act (VOASG) circumventing an ECJ ruling and mentions ongoing infringement proceedings by the European Commission against Germany. This content directly relates to significant lawsuits and regulatory actions involving the company. Therefore, it fits the definition of a Legal Proceedings Report (LTR). The document is short (2763 chars) and is a direct announcement/statement, not a formal regulatory filing like a 10-K or IR.
2020-12-14 English
Zur Rose Group AG: Olaf Heinrich, Head Germany, is leaving the Zur Rose Group; his successor will be Walter Hess, Head Switzerland
Board/Management Information Classification · 100% confidence The document is a press release announcing significant changes in senior management: the departure of Olaf Heinrich (Head Germany/CEO DocMorris) and the appointment of his successor, Walter Hess, along with another internal promotion. This content directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in senior management. It is not a financial report (10-K, IR, ER), a proxy statement (DEF 14A/PSI), or a general regulatory filing (RNS), as the primary subject is personnel changes.
2020-12-10 English
Digitale Verschreibung von Gesundheits-Apps
Regulatory Filings Classification · 100% confidence The document is a press release dated December 7, 2020, announcing that TeleClinic is launching a new portal to facilitate the prescription of 'Apps on Prescription' (DiGA) following the implementation of the Digitale-Versorgung-Gesetz (DVG). It details the process, eligibility, and lists specific approved digital health applications. This content is characteristic of a general corporate announcement or news release regarding a new service offering or regulatory compliance update, rather than a formal financial filing like a 10-K, Earnings Release (ER), or Interim Report (IR). Since it is a news announcement about a business development and does not fit the specific categories like AGM-R, 10-K, ER, or IR, the most appropriate classification is the general Regulatory Filings category (RNS), which often serves as a catch-all for significant, non-standard corporate news releases, especially those related to regulatory changes impacting operations. Given the context of a news detail page and the nature of the announcement, RNS is the best fit among the provided options.
2020-12-07 German
Zur Rose Group: gematik awards tender for specialist e-prescription service - Zur Rose subsidiary eHealth-Tec involved as partner to IBM
Regulatory Filings Classification · 99% confidence The document is explicitly labeled as an "Ad-hoc announcement" released on 16 November 2020, pursuant to Art. 53 KR (KAG/LG, Swiss Financial Market Infrastructure Act related regulations for ad-hoc disclosure). Ad-hoc announcements are used for material, non-public information that could significantly affect the share price. This type of disclosure, which is brief and reports on a specific business event (winning a tender), does not fit the definitions for 10-K (Annual Report), IR (Interim Report), ER (Earnings Release), or MDA (Management Discussion). It is a general regulatory disclosure of material news. Since it is not a specific report like a dividend notice (DIV) or a proxy statement (DEF 14A), and it is not announcing the publication of another report (RPA), the most appropriate general category for a mandatory, material, non-periodic disclosure that doesn't fit elsewhere is Regulatory Filings (RNS).
2020-11-16 English
Zur Rose Group accelerates growth in third quarter 2020
Earnings Release Classification · 100% confidence The document is titled 'News Details' and begins with a headline about accelerating growth in the 'third quarter 2020'. It explicitly uses the keyword 'Quarterly / Interim Statement' and provides detailed revenue figures for the third quarter (1.7.-30.9.2020) and the first nine months (1.1.-30.9.2020). This content structure—reporting on a period shorter than a full year with detailed financial metrics—is characteristic of an Interim Report. Since it is a comprehensive report for the first nine months, it fits the definition of an Interim / Quarterly Report (IR) rather than just an Earnings Release (ER) which is typically just highlights. The document length is substantial (12,457 chars), confirming it is the report content itself, not just an announcement of a report (RPA/RNS). Q3 2020
2020-10-21 English
Zur Rose and KPT together launch digital medicines assistant Medi+
Regulatory Filings Classification · 99% confidence The document is a 'Press release' announcing a partnership between Zur Rose and KPT to launch a digital medicines assistant called Medi+. It contains news details, contact information, and company descriptions, typical of a general corporate announcement disseminated via a news service (indicated by 'EQS Group-News'). This type of announcement, which is not a formal regulatory filing like a 10-K, earnings release (ER), or a specific financial report (IR, AR), fits best under the general category for regulatory/corporate news announcements that don't fit elsewhere, which is 'Regulatory Filings' (RNS) in this classification scheme, or potentially a general 'LTR' if it were legal/regulatory focused, but here it is purely commercial news. Given the options, RNS serves as the best general corporate news fallback.
2020-09-08 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.